Trial Information
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Inclusion Criteria:
- Premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant
or had at least one menstrual period in the last 12 months
- Women with newly diagnosed breast cancer (stage 0-III) or Diffuse Large B-cell
Lymphoma or Hodgkin's Lymphoma within 1 month of starting systemic treatment
- Breast cancer patients with any receptor type
- English speaking
- Able to participate in the informed consent process
Exclusion Criteria:
- Active secondary cancer requiring cytotoxic chemotherapy
- Prior systemic treatment for a malignancy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
determine the natural history of sexual and reproductive health
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Shari Goldfarb, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
12-249
NCT ID:
NCT01788839
Start Date:
February 2013
Completion Date:
February 2016
Related Keywords:
- Breast Cancer
- Lymphoma
- Hodgkin's Lymphoma
- Sexual and Reproductive Health
- premenopausal
- Fertility
- 12-249
- Breast Neoplasms
- Hodgkin Disease
- Lymphoma
Name | Location |
Memorial Sloan Kettering Cancer Center |
New York, New York 10021 |
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center |
Sleepy Hollow, New York 10591 |
Memorial Sloan-Kettering at Basking Ridge |
Basking Ridge, New Jersey 07920 |
Memorial Sloan-Kettering Cancer Center @ Suffolk |
Commack, New York 11725 |
Memorial Sloan-Kettering at Mercy Medical Center |
Rockville Centre, New York |